A detailed history of Lmr Partners LLP transactions in Black Diamond Therapeutics, Inc. stock. As of the latest transaction made, Lmr Partners LLP holds 30,100 shares of BDTX stock, worth $56,588. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30,100
Previous 206,400 85.42%
Holding current value
$56,588
Previous $897,000 92.87%
% of portfolio
0.0%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$2.14 - $4.17 $9,306 - $18,135
4,349 New
4,349 $9,000
Q1 2024

May 15, 2024

BUY
$2.67 - $5.74 $27,663 - $59,472
10,361 New
10,361 $52,000

Others Institutions Holding BDTX

About Black Diamond Therapeutics, Inc.


  • Ticker BDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,339,500
  • Market Cap $68.3M
  • Description
  • Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...
More about BDTX
Track This Portfolio

Track Lmr Partners LLP Portfolio

Follow Lmr Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.